CA whooping cough outbreak continues; Researcher explore plaque-preventing Alzheimer's vaccine;

> California has reported over 5,200 cases already this year, reports Forbes, including the death of nine babies. The state's declining vaccination rates has contributed to the outbreak. Report

> University of Texas Southwestern Medical Center researchers is developing a vaccine that help the immune system "gobble up" a protein molecule that plays a role in forming the plaque found in the brains of Alzheimer's patients. News

> The EMA has determined that there's no link between GSK's Pandemrix vaccine for H1N1 flu and narcolepsy. Story

> Los Angeles-based ImmunoCellular is using a new closed-bag system for production of its cancer vaccine candidate. The bag-based process, resulting from collaboration with the Clinical Cell and Vaccine Production Facility at the University of Pennsylvania, is churning out ICT-107, the company's lead product candidate. Report

> ImmunoCellular Therapeutics says it's developed an new way to manufacture the dendritic cell-based vaccine for the treatment of glioblastoma multiforme (GBM), a common type of brain tumor. Article

And Finally.. FDA's Top Q4 Blockbuster Drug Decisions. Article

Suggested Articles

GSK has formed several collaborations across the globe that will use its AS03 adjuvant to develop vaccines against the novel coronavirus.

Former FDA Commissioner Scott Gottlieb says 40% of the population needs to be vaccinated to achieve COVID-19 herd immunity.

CanSino Bio, Moderna and a collaboration between Oxford Univeristy and AstraZeneca are frontrunners, but they all face hurdles shared and unique.